Kiromic BioPharma
Financial ratios & Valuation

Historical Multiples (2018 – 2023)

2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-10.64-11.89-3.21-0.68-0.07-0.04-0.00-3.21
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
153.1422.545.430.63-0.51-0.100.200.63
Price/Cash Flow ratio
-18.87-15.31-10.07-0.85-0.12-0.04-0.00-10.07
Price/Free Cash Flow ratio
-17.74-13.87-8.13-0.78-0.10-0.04-0.00-8.13
Price/Earnings Growth ratio
N/A1.13-0.010.04-0.010.000.00-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
2.10%-0.60%-0.01%-0.25%-9.93%N/AN/A-0.01%
Return on Assets
-435.58%-141.38%-149.67%-83.48%-319.04%-174.98%-294.16%-83.48%
Return On Equity
-1438.25%-189.50%-169.01%-93.90%661.18%233.46%-257.82%-93.90%
Return on Capital Employed
-1199.62%-187.23%-168.95%-94.20%2364.66%242.88%-1824.63%-94.20%
Liquidity Ratios
Current Ratio
N/AN/A7.31N/AN/AN/A0.19N/A
Quick Ratio
0.892.997.317.930.120.210.037.93
Cash ratio
0.622.866.917.430.040.150.037.43
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
73.5492.60N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
988.521.88K1.21K1.72K1.29K278.85N/A1.72K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A0.030.010.601.150.970.03
Debt Equity Ratio
N/AN/A0.040.01-1.26-1.5344.820.04
Long-term Debt to Capitalization
N/AN/AN/AN/A-1.01N/A0.85N/A
Total Debt to Capitalization
N/AN/A0.030.014.832.860.880.03
Interest Coverage Ratio
N/AN/A-5.81KN/AN/AN/A-2.52K-5.81K
Cash Flow to Debt Ratio
N/AN/A-13.09-44.71-3.26-1.51-15.46-44.71
Company Equity Multiplier
3.301.341.121.12-2.07-1.3345.821.12
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.061.101.231.091.201.001.121.09
Cash Flow Coverage Ratio
N/AN/A-13.09-44.71-3.26-1.51-15.46-44.71
Short Term Coverage Ratio
N/AN/A-13.09-44.71-5.43-1.51-61.37-44.71
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A